167 related articles for article (PubMed ID: 3117118)
1. Inhibition of acyl-CoA synthetase by triacsins.
Tomoda H; Igarashi K; Omura S
Biochim Biophys Acta; 1987 Oct; 921(3):595-8. PubMed ID: 3117118
[TBL] [Abstract][Full Text] [Related]
2. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation.
Tomoda H; Igarashi K; Cyong JC; Omura S
J Biol Chem; 1991 Mar; 266(7):4214-9. PubMed ID: 1999415
[TBL] [Abstract][Full Text] [Related]
3. Triacsin C: a differential inhibitor of arachidonoyl-CoA synthetase and nonspecific long chain acyl-CoA synthetase.
Hartman EJ; Omura S; Laposata M
Prostaglandins; 1989 Jun; 37(6):655-71. PubMed ID: 2505330
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the reactivity of tetradecenoic acids, a triacsin, and unsaturated oximes with four purified Saccharomyces cerevisiae fatty acid activation proteins.
Knoll LJ; Schall OF; Suzuki I; Gokel GW; Gordon JI
J Biol Chem; 1995 Aug; 270(34):20090-7. PubMed ID: 7650027
[TBL] [Abstract][Full Text] [Related]
5. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
Vessey DA; Kelley M; Warren RS
J Biochem Mol Toxicol; 2004; 18(2):100-6. PubMed ID: 15122652
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolism inhibitors of microbial origin.
Tomoda H; Omura S
Kitasato Arch Exp Med; 1993 Apr; 65 Suppl():1-12. PubMed ID: 7967370
[TBL] [Abstract][Full Text] [Related]
7. Triacsins, new inhibitors of acyl-CoA synthetase produced by Streptomyces sp.
Omura S; Tomoda H; Xu QM; Takahashi Y; Iwai Y
J Antibiot (Tokyo); 1986 Sep; 39(9):1211-8. PubMed ID: 3781919
[TBL] [Abstract][Full Text] [Related]
8. Complementation of Saccharomyces cerevisiae strains containing fatty acid activation gene (FAA) deletions with a mammalian acyl-CoA synthetase.
Knoll LJ; Johnson DR; Gordon JI
J Biol Chem; 1995 May; 270(18):10861-7. PubMed ID: 7738025
[TBL] [Abstract][Full Text] [Related]
9. Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones.
Kim JH; Lewin TM; Coleman RA
J Biol Chem; 2001 Jul; 276(27):24667-73. PubMed ID: 11319222
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous long chain acyl-CoA synthetases control distribution of individual fatty acids in newly-formed glycerolipids of neuronal cells undergoing neurite outgrowth.
Li J; Wurtman RJ
Neurochem Res; 1999 Jun; 24(6):739-50. PubMed ID: 10447457
[TBL] [Abstract][Full Text] [Related]
11. Enhanced production of platelet-activating factor in stimulated rat leukocytes pretreated with triacsin C, A novel acyl-coA synthetase inhibitor.
Hayashi M; Imai Y; Naraba H; Tomoda H; Omura S; Oh-ishi S
Biochem Biophys Res Commun; 1992 Nov; 188(3):1280-5. PubMed ID: 1445360
[TBL] [Abstract][Full Text] [Related]
12. Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C.
Namatame I; Tomoda H; Arai H; Inoue K; Omura S
J Biochem; 1999 Feb; 125(2):319-27. PubMed ID: 9990129
[TBL] [Abstract][Full Text] [Related]
13. Long chain acyl coenzyme A and signaling in neutrophils. An inhibitor of acyl coenzyme A synthetase, triacsin C, inhibits superoxide anion generation and degranulation by human neutrophils.
Korchak HM; Kane LH; Rossi MW; Corkey BE
J Biol Chem; 1994 Dec; 269(48):30281-7. PubMed ID: 7982939
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting long-chain fatty acyl CoA synthetase does not increase agonist-induced release of arachidonate metabolites from human endothelial cells.
Weis MT; Brady M; Moore M; Crumley J; Stallone JN
J Vasc Res; 2005; 42(4):275-83. PubMed ID: 15908751
[TBL] [Abstract][Full Text] [Related]
15. The acyl-CoA synthetase inhibitor triacsin C enhanced eicosanoid release in leukocytes.
Oh-ishi S; Yamaki K; Abe M; Tomoda H; Omura S
Jpn J Pharmacol; 1992 Jul; 59(3):417-8. PubMed ID: 1434135
[TBL] [Abstract][Full Text] [Related]
16. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of acetoacetyl-CoA synthetase from rat liver by fatty acyl-CoAs.
Ito M; Fukui T; Saito T; Tomita K
Biochim Biophys Acta; 1987 Dec; 922(3):287-93. PubMed ID: 3689812
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium.
Weis MT; Crumley JL; Young LH; Stallone JN
Cardiovasc Res; 2004 Aug; 63(2):338-46. PubMed ID: 15249192
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.
Guo F; Zhang H; Fritzler JM; Rider SD; Xiang L; McNair NN; Mead JR; Zhu G
J Infect Dis; 2014 Apr; 209(8):1279-87. PubMed ID: 24273180
[TBL] [Abstract][Full Text] [Related]
20. Anti-atherosclerotic activity of triacsin C, an acyl-CoA synthetase inhibitor.
Matsuda D; Namatame I; Ohshiro T; Ishibashi S; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 May; 61(5):318-21. PubMed ID: 18653998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
